Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Pruzanski

Showing results (31-40 of 210) with videos related to

Pageof 21
Sort By:
The Journal of Rheumatology|October 1, 1992
Should tetracyclines be used in arthritis?W Pruzanski, P Vadas
The Journal of Rheumatology|April 1, 1990
Phospholipase A2 in articular cartilageW Pruzanski, P Vadas
The Journal of Rheumatology|October 1, 1983
Influence of agents with immunomodulating activity on phagocytosis and bactericidal function of human polymorphonuclear cellsW Pruzanski, S Saito
Canadian Medical Association Journal|May 22, 1976
Waldenström's macroglobulinemia: review of 45 casesM Krajny, W Pruzanski
Medicine|July 1, 1980
Plasma cell neoplasia with peripheral polyneuropathy. A study of five cases and a review of the literatureH Driedger, W Pruzanski
Canadian Medical Association Journal|May 23, 1970
IgD plasma cell neoplasia: clinical manifestations and characteristic featuresW Pruzanski, I Rother
Advances in Experimental Medicine and Biology|January 1, 1990
Phospholipase A2 activation is the pivotal step in the effector pathway of inflammationP Vadas, W Pruzanski
Annals of the Rheumatic Diseases|November 1, 1989
Phospholipase A2 and inflammationW Pruzanski, P Vadas
Arthritis and Rheumatism|July 1, 1996
Tenidap in rheumatoid arthritis: comment on the article by Blackburn et alW Pruzanski, P Vadas
Immunology Today|May 1, 1991
Phospholipase A2--a mediator between proximal and distal effectors of inflammationW Pruzanski, P Vadas
Pageof 21

Showing results (31-40 of 210) with videos related to

Sort By:
Pageof 21
The Journal of Rheumatology|October 1, 1992
Should tetracyclines be used in arthritis?W Pruzanski, P Vadas
The Journal of Rheumatology|April 1, 1990
Phospholipase A2 in articular cartilageW Pruzanski, P Vadas
The Journal of Rheumatology|October 1, 1983
Influence of agents with immunomodulating activity on phagocytosis and bactericidal function of human polymorphonuclear cellsW Pruzanski, S Saito
Canadian Medical Association Journal|May 22, 1976
Waldenström's macroglobulinemia: review of 45 casesM Krajny, W Pruzanski
Medicine|July 1, 1980
Plasma cell neoplasia with peripheral polyneuropathy. A study of five cases and a review of the literatureH Driedger, W Pruzanski
Canadian Medical Association Journal|May 23, 1970
IgD plasma cell neoplasia: clinical manifestations and characteristic featuresW Pruzanski, I Rother
Advances in Experimental Medicine and Biology|January 1, 1990
Phospholipase A2 activation is the pivotal step in the effector pathway of inflammationP Vadas, W Pruzanski
Annals of the Rheumatic Diseases|November 1, 1989
Phospholipase A2 and inflammationW Pruzanski, P Vadas
Arthritis and Rheumatism|July 1, 1996
Tenidap in rheumatoid arthritis: comment on the article by Blackburn et alW Pruzanski, P Vadas
Immunology Today|May 1, 1991
Phospholipase A2--a mediator between proximal and distal effectors of inflammationW Pruzanski, P Vadas
Pageof 21